Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / ScandiBio Therapeutics AB

Clinicaltrial registered22 Oct 2026

ScandiBio Therapeutics AB

22 Oct 2026: Trial registered · Combined Metabolic Activator Supplementation in Subjects Diagnosed With Gout. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
22 Oct 2026
Title
Combined Metabolic Activator Supplementation in Subjects Diagnosed With Gout
Conditions
Gout Disease
Phase
Phase 3
Study Type
Interventional
Status
Not Yet Recruiting
Countries
Turkey (Türkiye)
Country
Turkey (Türkiye)
Reference
NCT07889284
Location
Turkey (Türkiye)
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at ScandiBio Therapeutics AB

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Turkey (Türkiye)

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.